Table 5.
Summary of disease-related DNMT and TET mutations.
Protein | Disease | Alteration | Reference |
---|---|---|---|
DNMT1 | Hereditary sensory autonomic neuropathy with dementia and hearing loss (HSAN1E) | Y495C, Y495H, D490E-P491Y | Klein et al., 2011, 2013 |
DNMT1 | Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) | A570V, G605A, and V606F | Winkelmann et al., 2012 |
DNMT3A | Acute myeloid leukemia (AML) myelodysplastic syndrome (MDS) | R882 and frameshift, nonsense and splice site mutations |
Ley et al., 2011; Walter et al., 2011 |
DNMT3A | Overgrowth syndrome | Mutations interfere with domain–domain interactions and histone binding | Tatton-Brown et al., 2014 |
DNMT3B | Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF) syndrome | Mutations in catalytic domain |
Hansen et al., 1999; Xu et al., 1999 |
TET1 | AML | Ten-eleven translocation that gives rise to a MLL-TET1 fusion | Lorsbach et al., 2003 |
TET2 | AML, MDS, and myeloproliferative neoplasms | Mutations mostly in catalytic domain | Abdel-Wahab et al., 2009 |